Free tool
Drugs in development
Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations
Drugs in development
3,685
Not FDA-approved
In Phase 3
1,424
Highest phase reached
Matching your filters
502
502 drugs in development
Names, sponsors and conditions come from the trial records. Click a drug for its trials.
- DW5421APhase 31 trial
Daewon Pharmaceutical Co., Ltd. · Primary Hypercholesterolemia, Mixed Dyslipidemia
- DW5421BPhase 31 trial
Daewon Pharmaceutical Co., Ltd. · Primary Hypercholesterolemia, Mixed Dyslipidemia
- DWC202313Phase 31 trial
Daewoong Pharmaceutical Co. LTD. · Essential Hypertension
- DWC202404Phase 31 trial
Daewoong Pharmaceutical Co. LTD. · Hypertension, Essential Hypertension
- DWC202405Phase 31 trial
Daewoong Pharmaceutical Co. LTD. · Essential Hypertension
- DWC202518Phase 31 trial
Daewoong Pharmaceutical Co. LTD. · T2DM (Type 2 Diabetes Mellitus)
- F027Phase 31 trial
Shandong New Time Pharmaceutical Co., LTD · Type 2 Diabetes (T2DM)
- FDC laroprovstatPhase 31 trial
AstraZeneca · Hypercholesterolemia
- FDY-5301Phase 31 trial
Faraday Pharmaceuticals, Inc. · Acute Myocardial Infarction, STEMI, Percutaneous Coronary Revascularization
- FimasartanPhase 31 trial
Boryung Pharmaceutical Co., Ltd · Essential Hypertension
- HCP1803-4Phase 31 trial
Hanmi Pharmaceutical Company Limited · Hypertension
- HDM1702Phase 31 trial
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. · Obesity Control
- HGP2304-1Phase 31 trial
Hanmi Pharmaceutical Company Limited · Hypertension
- HGP2304-2Phase 31 trial
Hanmi Pharmaceutical Company Limited · Hypertension
- HPP2002-1Phase 31 trial
Hanmi Pharmaceutical Company Limited · Hypertension
- HPP2003-3Phase 31 trial
Hanmi Pharmaceutical Company Limited · Hypertension
- I004Phase 31 trial
Amphastar Pharmaceuticals, Inc. · Pharmacokinetics, Pharmacodynamics, Insulin Aspart
- IBI306Phase 31 trial
Innovent Biologics (Suzhou) Co. Ltd. · Non-Familial Hypercholesterolemia and Mixed Hyperlipidemia
- INCA033989Phase 31 trial
Incyte · Essential Thrombocythemia
- INS068Phase 31 trial
Jiangsu HengRui Medicine Co., Ltd. · Type 2 Diabetes
- Intravitreal RanibizumabPhase 31 trial
Roche (Genentech) · Diabetic Macular Edema
- JW0104Phase 31 trial
JW Pharmaceutical · Hypertension, Dyslipidemia
- JW0108Phase 31 trial
JW Pharmaceutical · Dyslipidemia
- JX10Phase 31 trial
Corxel Pharmaceuticals · Acute Ischemic Stroke
- L606Treprostinil LiposomePhase 31 trial
Liquidia Technologies, Inc. · Pulmonary Hypertension Due to Lung Disease (Disorder)
- LID104Phase 31 trial
EMS · Type 2 Diabetes Mellitus
- matched to CagrilintidePhase 31 trial
Novo Nordisk · Overweight, Obesity, Type 2 Diabetes
- MDR-001Phase 31 trial
MindRank AI Ltd · Overweight or Obesity
- NoiiglutidePhase 31 trial
Jiangsu HengRui Medicine Co., Ltd. · Type 2 Diabetes
- non-immunogenic staphylokinasePhase 31 trial
Supergene, LLC · Ischemic Stroke, Acute
- OPC-1085ELPhase 31 trial
Otsuka · Open Angle Glaucoma or Ocular Hypertension
- OtaplimastatSP-8203Phase 31 trial
Shin Poong Pharmaceutical Co. Ltd. · Ischemic Stroke
- PrusogliptinPhase 31 trial
CSPC Ouyi Pharmaceutical Co., Ltd. · Type 2 Diabetes
- QLG1091Phase 31 trial
Qilu Pharmaceutical Co., Ltd. · Type 2 Diabetes
- QR12000Phase 31 trial
Wuhan Createrna Science and Technology Co., Ltd · Essential Hypertension
- RC28-EPhase 31 trial
RemeGen Co., Ltd. · Diabetic Macular Edema (DME), wAMD
- Recombinant Human ProurokinaserhPro-UKPhase 31 trial
Tasly Biopharmaceuticals Co., Ltd. · Acute Ischemic Stroke AIS
- RilogrotugPhase 31 trial
AVEO Pharmaceuticals, Inc. · Cachexia; Cancer, Cachexia, Cachexia-Anorexia Syndrome
- RLD2001-2Phase 31 trial
Hanmi Pharmaceutical Company Limited · Hypertension
- RLD2209-1Phase 31 trial
Hanmi Pharmaceutical Company Limited · Hypertension
- RLD2209-2Phase 31 trial
Hanmi Pharmaceutical Company Limited · Hypertension
- SHPL-49Phase 31 trial
Shanghai Hutchison Pharmaceuticals Limited · Acute Ischemic Stroke
- SIM0811Phase 31 trial
Jiangsu Simcere Pharmaceutical Co., Ltd. · Acute Ischemic Stroke AIS
- SYH9056Phase 31 trial
CSPC ZhongQi Pharmaceutical Technology Co., Ltd. · Mild-to-moderate Essential Hypertension
- TCA108Phase 31 trial
EMS · Hypertension
- THP-00101Forxiga Tab.Phase 31 trial
THPharm Corp. · Type 2 Diabetes, Hypertension
- THP-00102Micardis Tab., THP-00103Phase 31 trial
THPharm Corp. · Type 2 Diabetes, Hypertension
- THP-00104Phase 31 trial
THPharm Corp. · Type 2 Diabetes, Hypertension
- THP-00105Phase 31 trial
THPharm Corp. · Type 2 Diabetes, Hypertension
- THP-00106Phase 31 trial
THPharm Corp. · Type 2 Diabetes, Hypertension
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.